Herbal Monograph
Tea Tree
Melaleuca alternifolia (Maiden & Betche) Cheel
Myrtaceae
Australia's premier topical antiseptic — broad-spectrum antimicrobial, antifungal, and anti-inflammatory essential oil
Overview
Plant Description
Melaleuca alternifolia is a small to medium-sized tree or tall shrub, typically growing 5-8 metres tall, occasionally reaching up to 14 metres in favorable conditions. The trunk is covered in a characteristic white, papery bark that peels in layers, giving rise to the common name 'paperbark.' The bark is thin, pale, and flaky on younger branches. The leaves are alternate, linear to linear-lanceolate, 10-35 mm long and 1 mm wide, giving the plant its 'narrow-leaved' descriptor. Leaves are soft, aromatic, and rich green, dotted with prominent oil glands (pellucid dots) visible when held to light. When crushed, the leaves release the characteristic strong, camphoraceous, medicinal scent of tea tree oil. Flowers are white to creamy white, borne in dense bottlebrush-like spikes 3-5 cm long, typically appearing from spring to early summer (October-December in Australia). Individual flowers are small, with 5 petals and numerous conspicuous white stamens that give the inflorescence its fluffy appearance. The fruit is a small, woody, cup-shaped capsule approximately 2-3 mm in diameter, clustered along the branches, each containing numerous tiny seeds. The root system is moderately deep with a spreading lateral root network, well adapted to periodically waterlogged soils.
Habitat
Melaleuca alternifolia is native to the subtropical coastal floodplains and swampy lowlands of northeastern New South Wales, Australia, extending slightly into southeastern Queensland. It grows naturally along watercourses, in seasonally inundated areas, and on poorly drained, low-lying alluvial flats. The species is well adapted to periodic flooding and waterlogging, and in its native range, it often forms dense stands (locally called 'tea tree swamps') in association with other Melaleuca species, Eucalyptus, and Casuarina. The preferred habitat features acidic, sandy to loamy soils with a high water table. The natural distribution is concentrated in a relatively restricted area centered on the Clarence, Richmond, and Orara river catchments of northeastern New South Wales, within a coastal strip roughly 100 km wide and 400 km long.
Distribution
The natural range of Melaleuca alternifolia is restricted to the North Coast and Northern Tablelands of New South Wales, Australia, and a small area of southeastern Queensland. This is a remarkably narrow natural distribution for a species of such global commercial importance. Commercial tea tree plantations have since been established throughout suitable areas of New South Wales and Queensland, as well as in other parts of Australia (Western Australia, Northern Territory). Significant plantation cultivation has also been established internationally, including in China (Yunnan, Guangxi, and Guangdong provinces, now one of the world's largest producers), South Africa, Zimbabwe, Kenya, India, Malaysia, Indonesia, and parts of Central and South America. The species thrives in warm, humid, subtropical to tropical climates with adequate rainfall (>900 mm annually) and well-drained to waterlogged acidic soils.
Parts Used
Essential oil (steam-distilled from leaves and terminal branchlets)
Preferred: Essential oil (topical application, diluted to 5-100% depending on indication)
The essential oil is the sole therapeutic preparation of Melaleuca alternifolia in modern practice. It is obtained exclusively by steam distillation of the fresh or partially dried leaves and terminal branch tips. The oil is a clear to pale yellow liquid with a characteristic fresh, camphoraceous, medicinal aroma. The chemical composition and quality are governed by the international standard ISO 4730:2017, which mandates a minimum of 30% terpinen-4-ol and a maximum of 15% 1,8-cineole. Commercial pharmaceutical-grade oils typically exceed 36% terpinen-4-ol. The whole leaf material is not used in herbal preparations.
Leaves (traditional use only)
Preferred: Crushed leaf poultice or infusion (historical/traditional use only)
In traditional Aboriginal Australian use, the leaves themselves were crushed and applied as poultices, or infused in water for wound washes. This reflects the indigenous method of accessing the antimicrobial volatile oils without distillation technology. Modern practice uses only the distilled essential oil, not crude leaf preparations.
Key Constituents
Monoterpene alcohols
The monoterpene alcohols, particularly terpinen-4-ol, are the primary pharmacological agents responsible for tea tree oil's antimicrobial, antifungal, and anti-inflammatory properties. Terpinen-4-ol disrupts microbial cell membrane permeability and integrity, leading to loss of membrane-bound functions including respiration and ion transport. It also inhibits the formation of pro-inflammatory cytokines in human monocytes, explaining the anti-inflammatory activity observed in clinical settings. The terpinen-4-ol content is the defining quality parameter per ISO 4730:2017.
Monoterpene hydrocarbons (cyclic)
The cyclic monoterpene hydrocarbons constitute the bulk of tea tree oil alongside the monoterpene alcohols. They contribute to antimicrobial activity through membrane disruption mechanisms and serve as biosynthetic precursors to the more pharmacologically potent terpinen-4-ol. The balance of these compounds relative to terpinen-4-ol and 1,8-cineole defines the oil chemotype and therapeutic quality. Oxidation of these hydrocarbons (particularly formation of p-cymene and peroxides from terpinenes) is the primary cause of decreased oil quality and increased sensitization risk in aged oils.
Monoterpene hydrocarbons (bicyclic)
The bicyclic monoterpene hydrocarbons are minor constituents that contribute modestly to the overall pharmacological profile of tea tree oil. Alpha-pinene has documented anti-inflammatory activity through inhibition of nuclear translocation of NF-kB and may contribute to the respiratory-soothing properties when the oil is used in steam inhalation preparations.
Oxide monoterpenes
1,8-Cineole is the key negative quality marker in tea tree oil. While pharmacologically active (mucolytic, anti-inflammatory, mild antimicrobial), it is not the desired primary constituent. High cineole content increases skin irritation risk and suggests inferior oil quality or incorrect species identification. The ISO 4730 upper limit of 15% was established to ensure therapeutic quality and reduce adverse reaction risk. Reputable suppliers maintain cineole below 5%.
Sesquiterpene hydrocarbons
The sesquiterpene hydrocarbons are minor constituents of tea tree oil that contribute to its aromatic profile and may provide supplementary anti-inflammatory and antimicrobial activity. Aromadendrene and viridiflorene are somewhat characteristic of Melaleuca-derived essential oils and can serve as botanical identity markers. Beta-caryophyllene, though present in trace amounts, is notable for its selective CB2 receptor agonist activity, contributing to anti-inflammatory effects.
Sesquiterpene alcohols
The sesquiterpene alcohols are present in low concentrations in M. alternifolia essential oil. While they possess intrinsic antimicrobial properties, their contribution to the overall therapeutic activity at the concentrations found in tea tree oil is minor. They are more significant as chemotaxonomic markers that help distinguish M. alternifolia oil from related Melaleuca species oils.
Oxidation products (degradation compounds)
Oxidation products are clinically significant because they transform tea tree oil from a well-tolerated therapeutic agent into a potential skin sensitizer. The allergic contact dermatitis attributed to tea tree oil in the dermatological literature is almost exclusively associated with oxidized oil containing elevated levels of peroxides, epoxides, and p-cymene. Fresh, properly stored oil (sealed, cool, dark conditions, used within 6-12 months of opening) has a very low sensitization risk. This distinction is critical for clinical practice and patient counseling.
Herbal Actions
Kills or inhibits the growth of microorganisms
Tea tree oil is one of the most extensively documented broad-spectrum topical antimicrobials in the herbal pharmacopoeia. Terpinen-4-ol and other components demonstrate activity against a wide range of Gram-positive bacteria (Staphylococcus aureus, including MRSA; Streptococcus pyogenes), Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa at higher concentrations), fungi (Candida albicans, dermatophytes including Trichophyton rubrum and T. mentagrophytes, Malassezia furfur), and some viruses (Herpes simplex virus). The primary mechanism involves disruption of microbial cell membrane integrity and inhibition of cellular respiration. Activity has been demonstrated in vitro with MIC values typically in the range of 0.25-2.0% (v/v) against susceptible organisms. Importantly, tea tree oil maintains activity against some antibiotic-resistant organisms including MRSA and fluconazole-resistant Candida strains.
[1, 4, 7, 15]Reduces inflammation
Topical anti-inflammatory activity is a well-documented property of tea tree oil, distinct from its antimicrobial action. Terpinen-4-ol suppresses the production of pro-inflammatory mediators including TNF-alpha, IL-1beta, IL-8, IL-10, and PGE2 in lipopolysaccharide-activated human monocytes and macrophages. The mechanism involves suppression of NF-kB-mediated transcription of pro-inflammatory cytokine genes. In clinical settings, anti-inflammatory effects are observed in acne (reduced redness and swelling of lesions), nickel-induced contact dermatitis (experimental model), and histamine-induced skin inflammation. The anti-inflammatory action complements the antimicrobial activity, making tea tree oil effective for conditions involving both infection and inflammation, such as acne vulgaris and infected wounds.
[1, 17, 20]Promotes wound healing
Tea tree oil promotes wound healing through multiple mechanisms: direct antimicrobial activity prevents wound infection, anti-inflammatory effects reduce excessive inflammation that can impair healing, and there is evidence of stimulation of monocyte differentiation and activation of macrophage-mediated wound debridement processes. Terpinen-4-ol enhances monocyte and macrophage phagocytic activity, supporting the inflammatory phase of wound healing. Traditional Aboriginal use centered on wound healing and prevention of infection in cuts, abrasions, and burns. Modern evidence supports its role in minor wound care, though it should not replace medical treatment for serious wounds.
[1, 3, 17]Stimulates and enhances immune response
Tea tree oil demonstrates local immunostimulant activity when applied topically. Terpinen-4-ol has been shown to enhance the differentiation and activity of human monocytes and increase the phagocytic capacity of macrophages. It suppresses the production of immunosuppressive cytokines (IL-10) while maintaining or enhancing pro-inflammatory and immune-activating mediators at the local tissue level. This local immune enhancement contributes to the resolution of skin infections and may partly explain the traditional observation of improved wound healing. The immunostimulant effect is local/topical rather than systemic, as tea tree oil is not taken internally.
[1, 17, 18]Promotes the discharge of mucus from the respiratory tract
When used in steam inhalation, the volatile components of tea tree oil (particularly 1,8-cineole and alpha-pinene) may promote mucociliary clearance and provide mild expectorant effects. This is not a primary therapeutic use and the evidence is largely based on the known pharmacology of the individual terpene components rather than specific clinical trials of tea tree oil for respiratory conditions. The aromatic and antimicrobial vapors may also provide a mild antiseptic effect on upper respiratory mucosa during inhalation. This use is traditional and supported by the pharmacology of individual constituents rather than direct clinical evidence for tea tree oil specifically.
[1, 3]Relieves pain
Tea tree oil provides mild local analgesic effects when applied topically to inflamed or irritated skin. The mechanism is primarily indirect, through reduction of inflammation and associated inflammatory pain mediators (PGE2, pro-inflammatory cytokines). There is also evidence of a mild local anesthetic effect from terpinen-4-ol. Aboriginal Australian traditional use includes application to relieve pain from insect bites, stings, and minor burns. The analgesic effect is modest and supplementary to the primary antimicrobial and anti-inflammatory actions.
[1, 3]Therapeutic Indications
Skin / Integumentary
Acne vulgaris (mild to moderate)
The landmark RCT by Bassett et al. (1990) compared 5% tea tree oil gel to 5% benzoyl peroxide lotion in 124 patients with mild to moderate acne. Both treatments significantly reduced inflamed and non-inflamed lesion counts over 3 months. Benzoyl peroxide had a faster onset of action, but tea tree oil was equally effective by the end of the study. Tea tree oil produced significantly fewer adverse effects (44% vs 79% reported side effects; P < 0.001), with markedly less scaling, dryness, and irritation. A Cochrane-style systematic review (Cao et al. 2015) confirmed tea tree oil's efficacy for acne, finding it comparable to conventional topical treatments. The mechanism combines direct antimicrobial activity against Cutibacterium acnes (formerly Propionibacterium acnes) with anti-inflammatory reduction of perifollicular inflammation. Clinical application: 5% tea tree oil in a gel or water-based vehicle, applied twice daily.
[1, 7, 14]Tinea pedis (athlete's foot)
Satchell et al. (2002) conducted a randomized, double-blind, placebo-controlled trial of 158 patients comparing 25% tea tree oil solution, 50% tea tree oil solution, and placebo for interdigital tinea pedis over 4 weeks. The clinical cure rate was significantly higher in both tea tree oil groups compared to placebo (25% TTO: 55% cure rate vs placebo 31%, P = 0.02; 50% TTO: 64% cure rate vs placebo 31%, P = 0.004). Mycological cure rates were also improved but did not reach statistical significance. An earlier trial by Tong et al. (1992) compared 10% tea tree oil cream to 1% tolnaftate and placebo, finding tea tree oil and tolnaftate equally superior to placebo in symptomatic relief, though tolnaftate was superior for mycological cure. These studies support tea tree oil as an effective topical treatment for mild to moderate tinea pedis, particularly for symptomatic relief.
[1, 8, 12]Onychomycosis (fungal nail infection)
Buck et al. (1994) conducted a randomized, double-blind trial comparing 100% tea tree oil to 1% clotrimazole solution in 117 patients with onychomycosis over 6 months. Both treatments were equally effective, with clinical improvement in approximately 60% of patients and mycological cure in approximately 11-18% in each group. A subsequent trial by Syed et al. (1999) found that a combination of 2% butenafine and 5% tea tree oil in cream produced significantly higher cure rates (80%) than placebo (0%) over 16 weeks. Tea tree oil alone is moderately effective for onychomycosis but may be best used as part of a combined approach or for early/mild cases. Full mycological cure with tea tree oil alone is difficult due to limited penetration of the nail plate.
[1, 10, 11]Minor wounds, cuts, and abrasions (antiseptic wound care)
Tea tree oil is widely used as a topical antiseptic for minor wound care based on its broad-spectrum antimicrobial activity and traditional Aboriginal use. While large-scale RCTs specifically for wound healing are limited, the antimicrobial efficacy against wound-relevant pathogens (S. aureus, MRSA, S. pyogenes, E. coli) is well-established in vitro. Brand et al. (2001) demonstrated that terpinen-4-ol enhanced monocyte differentiation, supporting the wound-healing process. Clinical use involves application of diluted tea tree oil (5-10% in a suitable carrier or aqueous vehicle) to clean, minor wounds. Not appropriate for deep, serious, or heavily contaminated wounds requiring medical attention. Registered as a topical antiseptic by the Australian Therapeutic Goods Administration (TGA).
[1, 6, 18]Seborrheic dermatitis and dandruff
Satchell et al. (2002) conducted a randomized, single-blind, parallel-group study comparing 5% tea tree oil shampoo to placebo shampoo in 126 patients with mild to moderate dandruff over 4 weeks. The tea tree oil shampoo produced a 41% improvement in dandruff severity compared to 11% in the placebo group (P < 0.001). Patients in the tea tree oil group also reported significantly reduced scalp itchiness and greasiness. The mechanism involves antifungal activity against Malassezia species (the yeasts implicated in seborrheic dermatitis and dandruff) combined with anti-inflammatory and mild keratolytic effects. 5% tea tree oil shampoo is now widely available commercially for this indication.
[1, 9]Impetigo and superficial skin infections
Tea tree oil demonstrates potent in vitro activity against the primary causative organisms of impetigo: Staphylococcus aureus (including MRSA) and Streptococcus pyogenes. MIC values for S. aureus are typically 0.25-0.5% (v/v). A pilot clinical study has suggested efficacy in the treatment of minor superficial skin infections, though large-scale RCTs are lacking. The combination of broad-spectrum antibacterial activity with anti-inflammatory and wound-healing properties makes tea tree oil a rational topical agent for superficial bacterial skin infections. However, it should not replace systemic antibiotics when indicated for extensive or complicated infections.
[1, 15]Herpes labialis (cold sores)
In vitro studies have demonstrated virucidal activity of tea tree oil against Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). Schnitzler et al. (2001) found that tea tree oil exhibited direct virucidal activity against free HSV-1 at concentrations as low as 0.0009% and inhibited cell-to-cell spread of the virus. The mechanism appears to involve disruption of the viral envelope. Clinical evidence is limited to anecdotal reports and small pilot studies. Tea tree oil may be applied neat or at 5-10% dilution at the first signs of a cold sore (prodromal tingling), though it is less established than other antiviral options.
[1, 19]Dermatophytosis (tinea corporis, tinea cruris, ringworm)
Tea tree oil demonstrates potent antifungal activity against all common dermatophyte species (Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum, Microsporum canis) with MIC values of 0.25-1.0% in vitro. While the RCT evidence is strongest for tinea pedis specifically, the consistent antifungal activity against the same dermatophyte species responsible for other superficial dermatophytoses supports its use for tinea corporis and tinea cruris. Traditional use and clinical experience in Australian dermatological practice support application at 25-50% concentration for dermatophyte infections.
[1, 8, 15]Vulvovaginal candidiasis (topical only)
Tea tree oil demonstrates potent in vitro activity against Candida albicans and other Candida species, including fluconazole-resistant strains. Hammer et al. (1998) documented MIC values of 0.25-0.5% for C. albicans. Clinical use involves diluted tea tree oil (typically 0.4-1% in a suitable vehicle) applied as a vaginal suppository or wash. A small pilot study suggested symptomatic improvement. However, large-scale clinical trials are lacking, and the vaginal mucosa requires careful attention to dilution to avoid irritation. This indication requires practitioner guidance and should not replace conventional antifungal treatment for confirmed vulvovaginal candidiasis.
[1, 16]Insect bites and stings (symptomatic relief)
Application of diluted tea tree oil to insect bites and stings for symptomatic relief is a traditional Aboriginal Australian use and a very common modern application. The anti-inflammatory action reduces swelling and itching, while the antimicrobial properties help prevent secondary infection of scratched bites. The mild local analgesic effect may also provide comfort. Evidence is largely experiential and traditional rather than from controlled clinical trials. Applied at 5-10% dilution to the affected area.
[1, 3]Burns (minor, superficial)
Traditional Australian use includes application to minor burns and sunburn. The antimicrobial action helps prevent secondary infection, the anti-inflammatory action reduces pain and swelling, and the vulnerary activity may support healing. Arthur Penfold's early work in the 1920s-1930s included observations of tea tree oil efficacy for minor burns. Modern clinical evidence from controlled trials is limited for this specific indication. Applied diluted (5-10%) in a suitable carrier. Not appropriate for severe, extensive, or blistered burns requiring medical treatment.
[1, 2, 3]Respiratory System
Upper respiratory congestion (steam inhalation)
Tea tree oil is traditionally used as a steam inhalation for symptomatic relief of nasal and upper respiratory congestion associated with colds and sinusitis. Two to three drops of essential oil are added to a bowl of hot water, and the aromatic steam is inhaled for 5-10 minutes with the head covered by a towel. The volatile terpenes, particularly 1,8-cineole and alpha-pinene, provide mild mucolytic and decongestant effects. The antimicrobial vapors may also provide local antiseptic action on respiratory mucosa. While widely practiced and pharmacologically plausible, there are no RCTs specifically evaluating tea tree oil steam inhalation for URI symptoms.
[1, 3]Immune System
MRSA decolonization (topical, adjunctive)
Tea tree oil demonstrates consistent in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA) with MIC values comparable to those for susceptible S. aureus strains (0.25-0.5%). Several clinical studies have investigated topical tea tree oil preparations for MRSA decolonization. Dryden et al. (2004) compared a tea tree oil-based body wash and nasal ointment regimen to standard mupirocin nasal ointment and chlorhexidine body wash in MRSA-colonized hospital patients, finding comparable decolonization rates. Caelli et al. (2000) found that a tea tree oil regimen was more effective than routine care for MRSA decolonization. However, a larger RCT by Blackwood et al. (2013) found no significant difference between tea tree oil and standard treatment. This indication remains under active investigation and is not yet a standard of care.
[1, 13, 15]Reproductive System
Bacterial vaginosis (topical, adjunctive)
In vitro studies have demonstrated activity of tea tree oil against Gardnerella vaginalis and other organisms associated with bacterial vaginosis. A small clinical study investigated tea tree oil pessaries as a treatment for bacterial vaginosis and reported symptom improvement in some participants. The antimicrobial spectrum of tea tree oil is relevant to the polymicrobial etiology of BV. However, clinical evidence is limited and this use requires practitioner supervision. Intravaginal application must use appropriately diluted preparations (typically 0.4-1% in a suitable base) to avoid mucosal irritation.
[1, 16]Digestive System
Oral candidiasis (thrush) — mouthwash only
Tea tree oil has demonstrated in vitro activity against oral Candida species. Diluted tea tree oil mouthwash preparations have been investigated for oral candidiasis, particularly in immunocompromised patients. Jandourek et al. (1998) reported improvement in oral candidiasis symptoms in AIDS patients using a tea tree oil oral solution. However, the evidence base is limited and internal use must be restricted to highly diluted mouthwash preparations that are expectorated and not swallowed. Concentrations of 0.5-1% tea tree oil in an aqueous or hydroalcoholic vehicle are used for oral rinse applications.
[1, 16]Energetics
Temperature
cool
Moisture
dry
Taste
Tissue States
hot/excitation (topical inflammation, infected and inflamed skin conditions), damp/stagnation (weeping or suppurating wounds, fungal overgrowth in moist skin folds)
Tea tree oil is classified as cool and dry in energetic terms, which aligns with its primary use in hot, inflamed, and damp tissue states. The cooling quality reflects its anti-inflammatory action on hot, red, swollen skin conditions such as acne, infected wounds, and inflammatory dermatitis. The drying quality corresponds to its astringent-like action on weeping, suppurating, or excessively moist conditions such as fungal infections in intertriginous areas and oozing dermatitis. The pungent and aromatic taste characteristics reflect the volatile terpene chemistry that penetrates tissues rapidly and provides the antimicrobial and circulatory-stimulating properties. In the tissue state model, tea tree oil is specifically indicated for hot/excitation states (inflamed, red, infected tissue) and damp/stagnation states (fungal overgrowth, weeping wounds, congested tissue). It would be less appropriate for cold, dry, atrophic tissue conditions where warming and moistening remedies are needed.
Traditional Uses
Australian Aboriginal medicine (Bundjalung people and related groups)
- Crushing leaves to create a poultice applied directly to wounds, cuts, and skin infections
- Infusing crushed leaves in warm water to create an antimicrobial wash for wound cleansing
- Bathing in lakes and pools where fallen tea tree leaves had created a natural antiseptic infusion
- Inhaling vapors from crushed leaves for respiratory congestion and colds
- Applying crushed leaves to insect bites and stings for relief of pain and swelling
- Treating burns, sores, and skin ailments with leaf preparations
- Using tea tree swamp waters (naturally infused with Melaleuca oils) for bathing to promote skin healing
"The Bundjalung Aboriginal people of the Bungawalbyn region in northeastern New South Wales had extensive traditional knowledge of M. alternifolia's medicinal properties. They used the crushed leaves as a poultice for wounds, skin infections, and sores, and prepared infusions for wound washing. The tradition of bathing in 'tea tree lakes' — shallow pools in tea tree swamps where natural leaf fall had created a warm, brown, antiseptic infusion — was a known therapeutic practice. European settlers in the region observed these practices and adopted topical use of crushed tea tree leaves in the late 19th and early 20th centuries."
Early European Australian bush medicine (19th-20th century)
- Adoption of Aboriginal wound-treatment practices using crushed tea tree leaves
- Use of crude tea tree oil as a general antiseptic and first-aid remedy in rural communities
- Application to cuts, scratches, and minor skin ailments in remote bush settings
- Inclusion in field first-aid kits during World War II (Australian military issue)
- General household disinfectant and antimicrobial agent
"European settlers in the Northern Rivers region of New South Wales adopted Aboriginal knowledge of tea tree's medicinal properties. Arthur Penfold, chief chemist of the Museum of Technology in Sydney, published the first scientific study of tea tree oil's antimicrobial properties in 1925, documenting that M. alternifolia essential oil had an antiseptic potency 11-13 times greater than carbolic acid (phenol), the standard disinfectant of the time. This finding catalyzed commercial interest. During World War II, tea tree oil was included in Australian military first-aid kits as a field antiseptic. Soldiers working in tea tree plantations were exempted from military service because the oil was deemed an essential commodity for the war effort."
Modern Western clinical aromatherapy
- Topical treatment of acne vulgaris (5% in gel or lotion)
- Antifungal treatment for athlete's foot, ringworm, and nail fungus
- Antiseptic wound care for minor cuts, abrasions, and grazes
- Dandruff and seborrheic dermatitis treatment (5% in shampoo)
- Steam inhalation for upper respiratory congestion
- Antimicrobial household cleaning and surface disinfection
- Deodorizing formulations utilizing antimicrobial action
- Oral hygiene (diluted mouthwash formulations)
- Insect bite and sting relief
"Tea tree oil experienced a major resurgence in popularity from the 1980s onward as part of the broader natural health movement. Clinical aromatherapy practice established standardized dilution guidelines (typically 5-10% for general topical use) and specific protocols for acne, fungal infections, and wound care. The publication of Bassett et al. (1990) — the first rigorous RCT of tea tree oil — catalyzed evidence-based adoption. The Australian Tea Tree Industry Association (ATTIA) was established in 1986 to promote quality standards and research. Tea tree oil became one of the most studied essential oils in the pharmacological literature."
Global dermatological practice
- Over-the-counter acne treatment products containing 5% tea tree oil
- Antifungal foot care products for prevention and treatment of athlete's foot
- Medicated shampoos for dandruff and seborrheic dermatitis
- Antiseptic skin cleansers and hand sanitizers
- Hospital-based MRSA decolonization protocols (investigational)
- Wound care products for minor cuts and abrasions
- Oral care products (toothpastes and mouthwashes containing tea tree oil)
"Tea tree oil has been incorporated into mainstream dermatological and pharmaceutical products globally. The European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) has issued a community herbal monograph on M. alternifolia essential oil, recognizing traditional topical use for small superficial wounds, insect bites, small boils (furuncles), and mild athlete's foot. The Australian Therapeutic Goods Administration (TGA) registers tea tree oil as an active pharmaceutical ingredient for topical antiseptic indications. These regulatory recognitions reflect the transition from folk remedy to evidence-based topical therapeutic."
Modern Research
Comprehensive review of Melaleuca alternifolia (tea tree) oil antimicrobial and anti-inflammatory properties
Major comprehensive review by Carson, Hammer, and Riley (2006) synthesizing the pharmacological, microbiological, and clinical evidence for tea tree oil. Covers the chemistry, antimicrobial spectrum, mechanisms of action, clinical trials, toxicology, and regulatory status. This paper is the most cited single reference in the tea tree oil literature and provides the foundational evidence base for clinical use.
Findings: Documented broad-spectrum antimicrobial activity against bacteria (including MRSA), fungi (dermatophytes, yeasts), viruses (HSV), and protozoa. Confirmed terpinen-4-ol as the primary bioactive component with well-characterized mechanism of membrane disruption. Reviewed clinical evidence supporting efficacy in acne, tinea pedis, onychomycosis, and dandruff. Documented anti-inflammatory mechanism via suppression of pro-inflammatory cytokine production. Reviewed safety profile including oxidation-dependent skin sensitization risk. Concluded that tea tree oil is a legitimate topical antimicrobial with a substantial evidence base supporting clinical use for several indications.
Limitations: Narrative review, not a systematic review with formal quality assessment. Authors are the leading research group in the field, which may introduce perspective bias. Published 2006; does not include more recent studies.
[1]
Tea tree oil versus benzoyl peroxide for acne vulgaris (landmark RCT)
Randomized, single-blind clinical trial comparing 5% tea tree oil gel to 5% benzoyl peroxide lotion in 124 patients with mild to moderate facial acne vulgaris over a period of 3 months. This is the foundational clinical trial that established tea tree oil as a legitimate acne treatment.
Findings: Both 5% tea tree oil and 5% benzoyl peroxide significantly reduced the number of inflamed and non-inflamed acne lesions. Benzoyl peroxide had a significantly faster onset of action. By study end (3 months), both treatments produced comparable reductions in lesion counts. Tea tree oil produced significantly fewer side effects: 44% of the tea tree oil group reported adverse effects versus 79% of the benzoyl peroxide group (P < 0.001). Benzoyl peroxide produced significantly more scaling, dryness, and redness. The authors concluded that tea tree oil gel is an effective alternative to benzoyl peroxide with fewer side effects, though with a slower onset.
Limitations: Single-blind (not double-blind) design. Conducted in 1990; study methodology would not fully meet current CONSORT standards. Only 5% concentration tested; higher concentrations were not evaluated. No placebo arm — the study compared two active treatments. Follow-up limited to 3 months.
[7]
Tea tree oil for tinea pedis (interdigital athlete's foot)
Randomized, double-blind, placebo-controlled trial of 158 patients with interdigital tinea pedis comparing 25% tea tree oil solution, 50% tea tree oil solution, and placebo applied twice daily for 4 weeks.
Findings: Clinical cure rates were significantly higher in both tea tree oil groups compared to placebo: 25% TTO achieved 55% clinical cure (P = 0.02 vs placebo), 50% TTO achieved 64% clinical cure (P = 0.004 vs placebo), and placebo achieved 31% clinical cure. Mycological cure (negative culture) rates were higher in the treatment groups but did not reach statistical significance (25% TTO: 52%, 50% TTO: 64%, placebo: 39%). Patient-reported symptom improvement (scaling, inflammation, itching) was significantly superior in both tea tree oil groups. Both concentrations were well tolerated with no treatment discontinuations due to adverse effects.
Limitations: Mycological cure rates, while improved, did not reach statistical significance, suggesting the symptom improvement may partly reflect anti-inflammatory effects rather than complete eradication of the fungal organism. Four-week treatment period may be insufficient for complete mycological cure. No long-term follow-up to assess relapse rates.
[8]
Tea tree oil for dandruff and seborrheic dermatitis
Randomized, single-blind, parallel-group study comparing 5% tea tree oil shampoo to placebo shampoo in 126 patients with mild to moderate dandruff over 4 weeks of daily use.
Findings: The 5% tea tree oil shampoo produced a 41% improvement in total dandruff severity area score compared to 11% improvement in the placebo group (P < 0.001). Patients using tea tree oil shampoo also reported significantly less itching and greasiness. The quadrant severity score and total severity score were both significantly improved. No adverse effects were reported in either group. The antifungal activity against Malassezia species combined with anti-inflammatory effects likely accounts for the clinical improvement.
Limitations: Single-blind design. Short duration (4 weeks). No comparison to standard anti-dandruff agents (ketoconazole, zinc pyrithione). Did not perform quantitative assessment of Malassezia colonization. No long-term follow-up or assessment of relapse after treatment cessation.
[9]
Tea tree oil for onychomycosis compared to clotrimazole
Randomized, double-blind trial comparing 100% (pure) tea tree oil to 1% clotrimazole solution in 117 patients with distal subungual onychomycosis of toenails over 6 months.
Findings: After 6 months of twice-daily application, both treatments produced similar outcomes. Clinical assessment rated 60% of the tea tree oil group and 61% of the clotrimazole group as fully or partially cured (no significant difference). Mycological cure (negative culture) was achieved in 11% of the tea tree oil group and 11% of the clotrimazole group. The authors concluded that tea tree oil and clotrimazole are equally effective for onychomycosis, though both have limited mycological cure rates for this notoriously difficult-to-treat condition.
Limitations: Low mycological cure rates in both groups (11%), reflecting the inherent difficulty of treating onychomycosis with topical agents alone. No placebo arm. Six-month treatment period may be insufficient for complete nail regrowth. Only toenail onychomycosis studied. The 100% concentration is not standard recommended use and may increase irritation risk.
[10]
In vitro antimicrobial activity of tea tree oil components
Comprehensive in vitro study characterizing the antimicrobial activity of tea tree oil and its major individual components against a panel of bacteria, yeasts, and dermatophytes.
Findings: Terpinen-4-ol was the most active single component against all microorganisms tested, with MIC values of 0.06-0.5% for bacteria and 0.12-0.25% for Candida albicans. The whole essential oil was generally more active than any single component, suggesting synergistic or additive interactions between constituents. Alpha-terpineol also demonstrated significant activity. Gamma-terpinene and alpha-terpinene showed moderate activity. 1,8-Cineole had the lowest antimicrobial activity of the major components. The study confirmed that terpinen-4-ol is the primary antimicrobial agent but that whole oil is therapeutically superior to isolated constituents.
Limitations: In vitro study; results may not directly translate to in vivo efficacy. MIC values determined in liquid culture may differ from those achievable in skin tissue. Does not account for pharmacokinetic factors such as skin penetration and local concentration. Single strain of each organism tested.
[15]
Anti-inflammatory mechanism of terpinen-4-ol from tea tree oil
Investigation of the anti-inflammatory mechanism of terpinen-4-ol in human monocytes and its effect on pro-inflammatory cytokine production.
Findings: Terpinen-4-ol suppressed the production of the pro-inflammatory mediators TNF-alpha, IL-1beta, IL-8, IL-10, and PGE2 in lipopolysaccharide (LPS)-activated human blood monocytes at concentrations achievable with topical application (0.016-0.125%). The suppression was dose-dependent and occurred at non-cytotoxic concentrations, confirming a specific anti-inflammatory effect rather than general cell toxicity. The mechanism involves modulation of the NF-kB inflammatory signaling pathway. This finding explains the clinical observation that tea tree oil reduces inflammation and redness in acne and other inflammatory skin conditions independently of its antimicrobial activity.
Limitations: In vitro monocyte model; in vivo tissue-level effects may differ. Isolated terpinen-4-ol tested rather than whole oil (synergistic effects of other components not captured). Does not address the relative contribution of anti-inflammatory vs antimicrobial effects to clinical outcomes.
[17]
Immunostimulant activity of terpinen-4-ol on human monocytes
Investigation of the effects of tea tree oil and terpinen-4-ol on human monocyte differentiation, activation, and function relevant to wound healing and immune defense.
Findings: Terpinen-4-ol enhanced the differentiation of immature human monocytes into active macrophage-like cells. Treatment increased cell adherence, spreading, and morphological differentiation markers. Phagocytic capacity was enhanced. The effect was dose-dependent and occurred at sub-cytotoxic concentrations. This immunostimulant activity at the local tissue level supports the wound-healing tradition and provides a mechanism for enhanced local immune defense against pathogens beyond direct antimicrobial killing.
Limitations: In vitro study using isolated monocytes; tissue-level immune modulation in vivo may differ. The clinical significance of enhanced monocyte differentiation for wound healing has not been directly demonstrated in human clinical trials. Single cell type studied.
[18]
Tea tree oil in vitro antiviral activity against Herpes simplex virus
Investigation of the antiviral activity of tea tree oil and eucalyptus oil against Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) using plaque reduction assays.
Findings: Tea tree oil exhibited virucidal activity against HSV-1 and HSV-2 in cell culture. The IC50 (50% inhibitory concentration) for plaque formation was 0.0009% for HSV-1 and 0.0008% for HSV-2. Tea tree oil was primarily active against free virus (virucidal) rather than inhibiting intracellular replication, suggesting its mechanism involves disruption of the viral lipid envelope. Maximal antiviral activity occurred when virus was pre-treated with tea tree oil before cell adsorption, confirming direct virucidal action. The extremely low concentrations required are notable and suggest potential clinical application for herpes labialis.
Limitations: In vitro study only. Clinical efficacy for herpes labialis has not been established by RCTs. The in vitro concentrations effective against free virus may not translate to the dynamic in vivo environment of a cold sore where virus replication is already established intracellularly. No pharmacokinetic data on achievable tissue concentrations.
[19]
Tea tree oil for MRSA decolonization in hospital patients
Randomized controlled trial comparing a tea tree oil-based decolonization regimen (5% tea tree oil body wash and 10% tea tree oil nasal cream) to conventional treatment (2% mupirocin nasal ointment, 4% chlorhexidine body wash, and silver sulfadiazine for skin lesions) in 236 MRSA-colonized hospital patients.
Findings: MRSA clearance rates were comparable between the tea tree oil regimen and conventional treatment. The tea tree oil group achieved a clearance rate of 41% compared to 49% for conventional treatment (no statistically significant difference). The tea tree oil regimen was significantly more effective than conventional treatment for clearing MRSA from superficial skin sites and wounds, while mupirocin was superior for nasal clearance. Tea tree oil was well tolerated with fewer adverse reactions than the conventional regimen. The authors concluded that tea tree oil preparations are a viable alternative for MRSA decolonization, particularly for patients who have failed mupirocin treatment or have mupirocin-resistant MRSA.
Limitations: Open-label design (not blinded). Single hospital site. Conventional treatment regimen included three agents versus two for tea tree oil, making the comparison somewhat unequal. Follow-up period was 48 hours post-treatment completion only; long-term recolonization rates were not assessed. Intention-to-treat analysis showed non-inferiority rather than superiority.
[13]
Systematic review of complementary therapies for acne vulgaris
Systematic review by Cao et al. (2015) evaluating the evidence for complementary and alternative therapies for acne, including tea tree oil, through assessment of randomized controlled trials.
Findings: The review identified tea tree oil as having the strongest evidence base among complementary therapies for acne. The Bassett et al. (1990) RCT was rated as providing moderate evidence for the efficacy of 5% tea tree oil gel compared to 5% benzoyl peroxide. Additional smaller studies supported the anti-acne activity. The review concluded that tea tree oil has 'some evidence of efficacy' for mild to moderate acne and is a reasonable complementary treatment option, particularly for patients who do not tolerate conventional treatments.
Limitations: The systematic review was broader than just tea tree oil (covered many complementary therapies), so the depth of tea tree oil-specific analysis was limited. Few high-quality RCTs met inclusion criteria. Heterogeneity of tea tree oil preparations and concentrations across studies limited pooled analysis.
[14]
Contact sensitization from oxidized tea tree oil
Investigations by Hausen et al. and subsequent researchers into the contact-sensitizing potential of tea tree oil, with identification of oxidation products as the responsible agents.
Findings: Studies established that fresh, non-oxidized tea tree oil has a very low sensitization rate, while oxidized oil containing elevated levels of peroxides, epoxides, and p-cymene is a significant contact sensitizer. Patch testing with aged/oxidized tea tree oil produced positive reactions in up to 5-10% of eczema patients in some series, while fresh oil rarely produced reactions. The key sensitizing agents identified were ascaridole-type endoperoxides formed from autoxidation of alpha-terpinene and 1,4-epoxy-p-menth-2-ene. The clinical implication is that proper storage (cool, dark, sealed) and timely use of tea tree oil are critical for safety. Oil older than 6-12 months after opening, or oil stored in warm or light-exposed conditions, should be discarded.
Limitations: Case series and patch test studies have inherent selection bias (conducted in dermatology clinics on patients already presenting with skin problems). The reported sensitization rates vary widely depending on the study population and the oxidation state of the test material. Standardization of the oxidation state of tea tree oil used in patch testing has not been achieved across studies.
Antifungal activity against Candida and dermatophyte species
Comprehensive in vitro evaluation of tea tree oil and terpinen-4-ol against a panel of clinically relevant Candida species and dermatophyte fungi, including drug-resistant strains.
Findings: Tea tree oil demonstrated potent antifungal activity against all Candida species tested: C. albicans (MIC 0.25-0.5%), C. glabrata (MIC 0.25-0.5%), C. tropicalis, C. parapsilosis, and C. krusei. Importantly, fluconazole-resistant Candida strains remained fully susceptible to tea tree oil, indicating no cross-resistance between azole antifungals and tea tree oil. Against dermatophytes, MIC values were 0.25-1.0% for Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum, and Microsporum canis. The mechanism involves disruption of fungal cell membrane integrity and inhibition of ergosterol biosynthesis pathway components. The retained activity against drug-resistant strains is clinically significant.
Limitations: In vitro results with standardized inoculum conditions; in vivo penetration to the site of infection (particularly nail plate) may limit clinical efficacy. MIC values were determined using broth microdilution; nail penetration and tissue binding were not assessed. Clinical correlation between MIC values and treatment outcomes requires further study.
Preparations & Dosage
Essential Oil
Strength: Dilutions: 5% (1 part oil to 19 parts carrier) for general use; 10% (1:9) for minor infections; 25% (1:3) for tinea pedis; 50% (1:1) for resistant fungal infections; 100% (neat) for onychomycosis or spot treatment (with caution). ISO 4730:2017 standard: minimum 30% terpinen-4-ol, maximum 15% 1,8-cineole.
Tea tree essential oil is obtained by steam distillation of the fresh leaves and terminal branchlets of M. alternifolia. The oil is a clear to pale golden-yellow mobile liquid with a characteristic fresh, camphoraceous, medicinal aroma. For therapeutic use, the oil must conform to ISO 4730:2017 (minimum 30% terpinen-4-ol, maximum 15% 1,8-cineole). TOPICAL USE ONLY — never ingest pure essential oil. For general topical application, dilute to 5-10% in a suitable carrier oil (e.g., jojoba, sweet almond, fractionated coconut oil), aqueous cream, or gel vehicle. For acne: 5% in an aloe vera or water-based gel. For fungal infections: 25-50% in a suitable vehicle. For antiseptic wound care: 5-10% in aqueous solution or cream. May be used undiluted (neat) only on very small areas such as individual pimples or insect bites, with caution and only with fresh, non-oxidized oil. Store in dark glass bottles, tightly sealed, in a cool place away from light and heat. Discard after 6-12 months of opening to minimize oxidation and sensitization risk.
Topical: 5-10% dilution for general skin care and minor wounds; 5% in gel for acne (twice daily); 25-50% for tinea pedis (twice daily); 100% for onychomycosis (twice daily); 5% in shampoo for dandruff (daily). Steam inhalation: 2-3 drops in a bowl of hot water, inhale for 5-10 minutes. Mouthwash: 0.5-1% in water or hydroalcoholic solution, gargle and spit (do not swallow).
Typically applied 2-3 times daily for active infections or acne; 1-2 times daily for general antiseptic care; once daily for dandruff shampoo
Acne: minimum 4-8 weeks for assessment of response; ongoing use as needed. Tinea pedis: 4-6 weeks minimum. Onychomycosis: 6-12 months (full nail regrowth cycle). Wound care: until healing is complete. Dandruff: ongoing maintenance use.
Not recommended for children under 6 months. For children 6 months-12 years: use only at 1-2% dilution in a suitable carrier. Avoid use near the face in infants and young children due to risk of respiratory distress from menthol/cineole inhalation. Patch test before first use. Keep out of reach of children — essential oil ingestion is a medical emergency in children.
The essential oil is the primary and virtually only preparation of M. alternifolia used in modern practice. Quality is paramount: only purchase oil from reputable suppliers that provide ISO 4730 certification and batch-specific GC-MS (gas chromatography-mass spectrometry) analysis certificates. Tea tree oil is monographed in the British Pharmacopoeia and European Pharmacopoeia, providing official quality standards for pharmaceutical use. Terpinen-4-ol content of 36-42% or higher is preferred. Avoid oils with 1,8-cineole above 5% for therapeutic use. OXIDATION IS THE PRIMARY SAFETY CONCERN: oxidized oil (stored improperly, exposed to air/heat/light, or older than 12 months after opening) develops peroxides and epoxides that are potent skin sensitizers. Discard oil that smells harsh, turpentine-like, or different from fresh oil. Refrigeration extends shelf life. The oil is FOR EXTERNAL USE ONLY — oral ingestion of pure tea tree oil can cause CNS depression, ataxia, drowsiness, and, in severe cases, coma. It is HEPATOTOXIC TO CATS — never use on or around felines.
Salve / Ointment
Strength: 5-10% tea tree essential oil in ointment or cream base
Tea tree oil salve (ointment or cream): Melt 30 g beeswax with 120 mL carrier oil (e.g., sweet almond, olive, or coconut oil) in a double boiler. Remove from heat and allow to cool slightly (to approximately 40-45 degrees Celsius). Add 5-10 mL (approximately 5-8% concentration) of tea tree essential oil and stir thoroughly. Pour into clean, dark glass or tin containers and allow to set. Alternatively, commercial aqueous creams or emulsifying ointments can be used as a base: simply add 5-10% tea tree oil by volume and mix thoroughly. Store in a cool, dark place. Use within 3-6 months.
Apply a thin layer to the affected area 2-3 times daily. For wound care, apply after cleaning the wound. For fungal infections, apply generously and allow to be absorbed.
Two to three times daily
Continue until condition resolves. For fungal infections: minimum 2-4 weeks beyond apparent clinical resolution to prevent relapse.
Use a lower concentration (2-5% tea tree oil in the base) for children over 2 years. Not recommended for infants under 6 months.
Salve or ointment preparations provide sustained contact between tea tree oil and the affected skin, improving therapeutic outcomes for conditions requiring prolonged exposure (e.g., fungal infections, chronic wounds). The occlusive base also helps reduce evaporation of the volatile terpenes. An anhydrous ointment (beeswax/oil base) is preferred for dry, scaly conditions, while an aqueous cream (oil-in-water emulsion) is preferred for weeping or exudative conditions and for acne. A combination product containing tea tree oil with other synergistic essential oils (such as lavender for added wound-healing and soothing properties) is a traditional aromatherapy approach.
Poultice
Strength: Fresh crushed leaves (traditional) or 5-10 drops essential oil on a warm moist compress (modern adaptation)
Traditional Aboriginal method: Gather fresh M. alternifolia leaves. Crush thoroughly between the hands, in a mortar, or by bruising with a stone to release the aromatic oils. Apply the crushed leaf material directly to the wound, cut, or affected area. Cover with a clean cloth or bandage. Modern adaptation: Add 5-10 drops of tea tree essential oil to a warm, moist compress (clean cloth soaked in warm water, wrung out). Apply to the affected area for 15-30 minutes. Alternatively, make a strong infusion of fresh tea tree leaves if available (a handful of leaves steeped in boiling water for 10-15 minutes), soak a clean cloth, and apply as a warm compress.
Apply poultice or compress for 15-30 minutes, 2-3 times daily. Replace with fresh material for each application.
Two to three times daily
Until wound healing is progressing or infection has resolved
Supervised use only in children over 2 years. Use fewer drops of essential oil (2-3 drops) on the compress.
The poultice is the original traditional Aboriginal preparation method and provides direct contact between the antimicrobial plant material and the wound. While not commonly used in modern clinical practice (the essential oil having largely replaced crude leaf preparations), understanding the traditional method is historically and ethnobotanically important. The warm, moist compress adaptation is useful for infected wounds, boils, and abscesses where the combination of warmth (promoting circulation and drainage) and antimicrobial essential oil can be beneficial.
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Individuals with confirmed allergic contact dermatitis to tea tree oil (typically diagnosed by positive patch test) must avoid all topical exposure. Contact sensitization occurs almost exclusively with oxidized oil containing elevated peroxide levels, but once sensitized, the individual may react to both fresh and oxidized oil. Cross-reactivity with other terpene-containing essential oils (e.g., lavender, ylang-ylang) is possible but uncommon.
Tea tree essential oil is NOT FOR INTERNAL USE at full strength. Oral ingestion can cause serious systemic toxicity including central nervous system depression (drowsiness, confusion, ataxia, loss of coordination, coma in severe cases), gastrointestinal irritation (nausea, vomiting, diarrhea, abdominal pain), and, rarely, hepatotoxicity. Multiple cases of accidental and intentional ingestion have been reported to poison control centers. Even small volumes (less than 10 mL) can cause symptoms in children. This is a medical emergency requiring immediate medical attention. Highly diluted oral preparations (mouthwashes at 0.5-1% that are gargled and expectorated) are the only acceptable near-oral use.
Tea tree oil is hepatotoxic to cats due to their deficiency in glucuronyl transferase, a key hepatic enzyme required for the metabolism and excretion of terpenes and phenolic compounds. Dermal application of tea tree oil to cats has caused serious adverse effects including CNS depression, tremors, ataxia, weakness, hypothermia, and, in severe cases, death. Even diffusing tea tree oil in enclosed spaces with cats can cause adverse effects. This is well-documented in veterinary toxicology literature. Tea tree oil must never be applied to cats or used in environments where cats may be exposed to concentrated vapors.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Topical medications applied to the same area (Various topical therapeutics) | minor | Tea tree oil may alter the absorption of other topically applied medications by modifying skin barrier permeability. Terpenes, including terpinen-4-ol and 1,8-cineole, are known skin penetration enhancers that can increase transdermal absorption of co-applied substances. This could theoretically increase the local or systemic absorption of concurrently applied topical drugs. |
| Systemic drugs (no significant interactions known for topical tea tree oil use) (General systemic medications) | theoretical | When used topically as directed, systemic absorption of tea tree oil is minimal and unlikely to produce pharmacokinetically significant drug interactions. Tea tree oil is NOT taken internally, so hepatic CYP-mediated drug interactions are not a practical concern at therapeutic topical doses. |
Pregnancy & Lactation
Pregnancy
likely safe
Lactation
likely safe
There are no controlled clinical studies of tea tree oil use during pregnancy or lactation. However, topical use of appropriately diluted tea tree oil (5-10%) on small areas is generally considered low-risk during pregnancy and lactation because systemic absorption from topical application is minimal. Tea tree oil has been widely used topically during pregnancy without documented adverse fetal effects. The European Medicines Agency (EMA) community herbal monograph does not specifically contraindicate topical use in pregnancy. Precautionary recommendations: avoid application to the breast/nipple area during lactation (to prevent infant oral exposure), use only on small areas at standard dilutions, avoid prolonged or extensive application, and discontinue if any skin reaction occurs. Internal use is absolutely contraindicated in pregnancy as with all individuals.
Adverse Effects
References
Monograph Sources
- [1] Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties. Clin Microbiol Rev (2006) ; 19 : 50-62 . DOI: 10.1128/CMR.19.1.50-62.2006 . PMID: 16418522
- [2] Penfold AR, Grant R. The germicidal values of some Australian essential oils and their pure constituents, together with those for some essential oil isolates and synthetics. Part III. J R Soc N S W (1925) ; 59 : 346-349
- [3] Low T. Bush Medicine: A Pharmacopoeia of Natural Remedies. HarperCollins Publishers, Sydney (1990) . ISBN: 978-0-7322-2674-3
- [4] International Organization for Standardization. ISO 4730:2017 Essential oil of Melaleuca, terpinen-4-ol type (Tea Tree oil). International Organization for Standardization, Geneva (2017)
- [5] European Medicines Agency Committee on Herbal Medicinal Products (HMPC). Community Herbal Monograph on Melaleuca alternifolia (Maiden and Betche) Cheel, M. linariifolia Smith, M. dissitiflora F. Mueller and/or other species of Melaleuca, aetheroleum. European Medicines Agency, London (2013)
- [6] Australian Therapeutic Goods Administration (TGA). Permissible ingredients for listed medicines in Australia: Melaleuca alternifolia leaf oil (tea tree oil). Australian Government Department of Health, Canberra (2019)
Clinical Studies
- [7] Bassett IB, Pannowitz DL, Barnetson RS. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust (1990) ; 153 : 455-458 . DOI: 10.5694/j.1326-5377.1990.tb126150.x . PMID: 2145499
- [8] Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Australas J Dermatol (2002) ; 43 : 175-178 . DOI: 10.1046/j.1440-0960.2002.00590.x . PMID: 12121393
- [9] Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol (2002) ; 47 : 852-855 . DOI: 10.1067/mjd.2002.122734 . PMID: 12451368
- [10] Buck DS, Nidorf DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract (1994) ; 38 : 601-605 . PMID: 8195735
- [11] Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health (1999) ; 4 : 284-287 . DOI: 10.1046/j.1365-3156.1999.00396.x . PMID: 10320656
- [12] Tong MM, Altman PM, Barnetson RS. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol (1992) ; 33 : 104-108 . DOI: 10.1111/j.1440-0960.1992.tb00081.x . PMID: 1303075
- [13] Dryden MS, Dailly S, Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect (2004) ; 56 : 283-286 . DOI: 10.1016/j.jhin.2004.01.008 . PMID: 15066738
- [14] Cao H, Yang G, Wang Y, Liu JP, Smith CA, Luo H, Liu Y. Complementary therapies for acne vulgaris. Cochrane Database Syst Rev (2015) ; 1 : CD009436 . DOI: 10.1002/14651858.CD009436.pub2 . PMID: 25597924
Traditional Texts
- [15] Hammer KA, Carson CF, Riley TV. Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J Appl Microbiol (2003) ; 95 : 853-860 . DOI: 10.1046/j.1365-2672.2003.02059.x . PMID: 12969301
- [16] Hammer KA, Carson CF, Riley TV. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp.. J Antimicrob Chemother (1998) ; 42 : 591-595 . DOI: 10.1093/jac/42.5.591 . PMID: 9848442
- [17] Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res (2000) ; 49 : 619-626 . DOI: 10.1007/s000110050639 . PMID: 11131302
- [18] Brand C, Ferrante A, Prager RH, Riley TV, Carson CF, Finlay-Jones JJ, Hart PH. The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res (2001) ; 50 : 213-219 . DOI: 10.1007/s000110050746 . PMID: 11392609
- [19] Schnitzler P, Schon K, Reichling J. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie (2001) ; 56 : 343-347 . PMID: 11338678
- [20] Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol (2002) ; 147 : 1212-1217 . DOI: 10.1046/j.1365-2133.2002.05034.x . PMID: 12452873
Pharmacopeias & Reviews
- [21] British Pharmacopoeia Commission. British Pharmacopoeia 2024: Tea Tree Oil. The Stationery Office, London (2024)
- [22] European Directorate for the Quality of Medicines. European Pharmacopoeia 11th Edition: Melaleuca Oil. Council of Europe, Strasbourg (2023)
- [23] Australian Government Department of Health. Therapeutic Goods (Permissible Ingredients) Determination: Melaleuca alternifolia leaf oil. Australian Government, Canberra (2019)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.